MedPath

Piperine effect on caffeine salivary concentratio

Not Applicable
Conditions
Pharmacokinetics.
General examination and investigation of persons without complaint and reported diagnosis
Registration Number
IRCT201209239271N3
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

After providing adequate information to the subjects, eligible healthy volunteer will be enrolled in the study. be healthy; normal diet; not receiving microsomal enzyme inhibitor or inducer agents for at least 7 days before the study; not using black pepper for at least 7 days before the study; not using caffeine containing product 48 h before the study. Exclusion criteria: age below 18 and above 35; smoking; pregnancy; metabolic disorders; high pepper diet, receiving enzyme inhibitors or inducers.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Caffeine Saliva Concentration. Timepoint: Only once in fourth day of the study 0, 0.5, 2.5 and 5 h after taking Caffeine. Method of measurement: Using HPLC method (reverse phase; Water 25, Methanol 75, flow rate 0.8 ml/min, maximum wave length 242 nm).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath